What is she best known for?
The fields of study she is best known for:
The scientist’s investigation covers issues in Biochemistry, Signal transduction, Proteome, Cancer cell and Cancer research.
Her work in Enzyme, Beta oxidation, Ubiquitin and TRIB3 are all subfields of Biochemistry research.
By researching both Signal transduction and Dephosphorylation, Sherry Niessen produces research that crosses academic boundaries.
Her Proteome research is multidisciplinary, incorporating perspectives in Drug discovery and Active site.
Her research in Active site focuses on subjects like Proteomics, which are connected to Computational biology.
Her work in Cancer cell addresses subjects such as Fatty acid, which are connected to disciplines such as Metabolism, Transplantation and Phenotype.
Her most cited work include:
- Monoacylglycerol Lipase Regulates a Fatty Acid Network that Promotes Cancer Pathogenesis (655 citations)
- The CREB coactivator TORC2 functions as a calcium- and cAMP-sensitive coincidence detector. (522 citations)
- A conserved protein network controls assembly of the outer kinetochore and its ability to sustain tension (353 citations)
What are the main themes of her work throughout her whole career to date?
Sherry Niessen mostly deals with Biochemistry, Cell biology, Proteomics, Molecular biology and Signal transduction.
Her Biochemistry research focuses on Enzyme, Serine hydrolase, Serine, Activity-based proteomics and Protease.
Her Cell biology research is multidisciplinary, incorporating elements of Spindle apparatus and Spindle checkpoint.
The study incorporates disciplines such as Proteome, Peptide sequence, Pharmacology and Active site in addition to Proteomics.
In her study, Tumor progression, Cancer cell and Cancer is inextricably linked to Cell culture, which falls within the broad field of Molecular biology.
Her research on Signal transduction also deals with topics like
- Kinase which intersects with area such as Covalent bond,
- Phosphorylation which is related to area like Pancreatic cancer.
She most often published in these fields:
- Biochemistry (43.96%)
- Cell biology (25.27%)
- Proteomics (18.68%)
What were the highlights of her more recent work (between 2013-2021)?
- Biochemistry (43.96%)
- Cell biology (25.27%)
- Proteomics (18.68%)
In recent papers she was focusing on the following fields of study:
Her primary areas of study are Biochemistry, Cell biology, Proteomics, Molecular biology and T790M.
The concepts of her Biochemistry study are interwoven with issues in Cancer and Senescence.
Her work carried out in the field of Cell biology brings together such families of science as Regulator, Farnesyltransferase, Prenylation and Platelet activation.
As part of one scientific family, Sherry Niessen deals mainly with the area of Proteomics, narrowing it down to issues related to the Drug discovery, and often Genetics, Diabetes mellitus genetics and Phenotype.
She combines subjects such as Immunoglobulin light chain, Cell culture and Protein structure with her study of Molecular biology.
Her research integrates issues of Covalent bond and Proteome in her study of Kinase.
Between 2013 and 2021, her most popular works were:
- A road map to evaluate the proteome-wide selectivity of covalent kinase inhibitors (185 citations)
- Integrated phenotypic and activity-based profiling links Ces3 to obesity and diabetes (81 citations)
- A structurally distinct human mycoplasma protein that generically blocks antigen-antibody union. (59 citations)
In her most recent research, the most cited papers focused on:
Proteomics, Drug discovery, Molecular biology, T790M and Mutation are her primary areas of study.
Her biological study spans a wide range of topics, including Phenotype, Phenotypic screening, Proteome and Small Molecule Libraries.
Her study with Proteome involves better knowledge in Biochemistry.
As part of her studies on Biochemistry, Sherry Niessen often connects relevant areas like Immunoglobulin light chain.
Her studies in Drug discovery integrate themes in fields like Covalent bond, Genetics, Diabetes mellitus genetics and Active site.
Her research in Mutation intersects with topics in Reactivity, Potency and Cancer research.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
